A citation-based method for searching scientific literature

Matthew P Banegas, Christopher I Li. Breast Cancer Res Treat 2012
Times Cited: 50







List of co-cited articles
262 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Disparities in breast cancer characteristics and outcomes by race/ethnicity.
Siew Loon Ooi, Maria Elena Martinez, Christopher I Li. Breast Cancer Res Treat 2011
187
48

Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study.
Lisa A Carey, Charles M Perou, Chad A Livasy, Lynn G Dressler, David Cowan, Kathleen Conway, Gamze Karaca, Melissa A Troester, Chiu Kit Tse, Sharon Edmiston,[...]. JAMA 2006
26

Racial/ethnic differences in initiation of adjuvant hormonal therapy among women with hormone receptor-positive breast cancer.
Jennifer C Livaudais, Dawn L Hershman, Laurel Habel, Lawrence Kushi, Scarlett Lin Gomez, Christopher I Li, Alfred I Neugut, Louis Fehrenbacher, Beti Thompson, Gloria D Coronado. Breast Cancer Res Treat 2012
58
16

Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina Breast Cancer Study.
Katie M O'Brien, Stephen R Cole, Chiu-Kit Tse, Charles M Perou, Lisa A Carey, William D Foulkes, Lynn G Dressler, Joseph Geradts, Robert C Millikan. Clin Cancer Res 2010
254
16

Characteristics associated with differences in survival among black and white women with breast cancer.
Jeffrey H Silber, Paul R Rosenbaum, Amy S Clark, Bruce J Giantonio, Richard N Ross, Yun Teng, Min Wang, Bijan A Niknam, Justin M Ludwig, Wei Wang,[...]. JAMA 2013
188
16

The association of race/ethnicity, insurance status, and socioeconomic factors with breast cancer care.
Rachel A Freedman, Katherine S Virgo, Yulei He, Alexandre L Pavluck, Eric P Winer, Elizabeth M Ward, Nancy L Keating. Cancer 2011
136
14


Racial disparities in breast cancer diagnosis and treatment by hormone receptor and HER2 status.
Lu Chen, Christopher I Li. Cancer Epidemiol Biomarkers Prev 2015
59
14

Migration history, acculturation, and breast cancer risk in Hispanic women.
Esther M John, Amanda I Phipps, Adam Davis, Jocelyn Koo. Cancer Epidemiol Biomarkers Prev 2005
153
12

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials.
C Davies, J Godwin, R Gray, M Clarke, D Cutter, S Darby, P McGale, H C Pan, C Taylor, Y C Wang,[...]. Lancet 2011
12

Association between prescription co-payment amount and compliance with adjuvant hormonal therapy in women with early-stage breast cancer.
Alfred I Neugut, Milayna Subar, Elizabeth Ty Wilde, Scott Stratton, Corey H Brouse, Grace Clarke Hillyer, Victor R Grann, Dawn L Hershman. J Clin Oncol 2011
217
12

Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer.
Dawn L Hershman, Theresa Shao, Lawrence H Kushi, Donna Buono, Wei Yann Tsai, Louis Fehrenbacher, Marilyn Kwan, Scarlett Lin Gomez, Alfred I Neugut. Breast Cancer Res Treat 2011
474
12

US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status.
Nadia Howlader, Sean F Altekruse, Christopher I Li, Vivien W Chen, Christina A Clarke, Lynn A G Ries, Kathleen A Cronin. J Natl Cancer Inst 2014
584
12


Differences in breast cancer stage, treatment, and survival by race and ethnicity.
Christopher I Li, Kathleen E Malone, Janet R Daling. Arch Intern Med 2003
507
10

Genetic ancestry and risk factors for breast cancer among Latinas in the San Francisco Bay Area.
Elad Ziv, Esther M John, Shweta Choudhry, Jennifer Kho, Wendy Lorizio, Eliseo J Perez-Stable, Esteban Gonzalez Burchard. Cancer Epidemiol Biomarkers Prev 2006
44
11

Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients.
Lisa K Dunnwald, Mary Anne Rossing, Christopher I Li. Breast Cancer Res 2007
444
10


Racial/ethnic differences in use and duration of adjuvant hormonal therapy for breast cancer in the women's health initiative.
Jennifer C Livaudais, Andrea Lacroix, Rowan T Chlebowski, Christopher I Li, Laurel A Habel, Michael S Simon, Beti Thompson, Deborah O Erwin, F Allan Hubbell, Gloria D Coronado. Cancer Epidemiol Biomarkers Prev 2013
20
25

Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer.
Ann H Partridge, Philip S Wang, Eric P Winer, Jerry Avorn. J Clin Oncol 2003
480
10

Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients.
Dawn L Hershman, Lawrence H Kushi, Theresa Shao, Donna Buono, Aaron Kershenbaum, Wei-Yann Tsai, Louis Fehrenbacher, Scarlett Lin Gomez, Sunita Miles, Alfred I Neugut. J Clin Oncol 2010
506
10

Racial and Ethnic Differences in Breast Cancer Survival: Mediating Effect of Tumor Characteristics and Sociodemographic and Treatment Factors.
Erica T Warner, Rulla M Tamimi, Melissa E Hughes, Rebecca A Ottesen, Yu-Ning Wong, Stephen B Edge, Richard L Theriault, Douglas W Blayney, Joyce C Niland, Eric P Winer,[...]. J Clin Oncol 2015
148
10

Effectiveness of aromatase inhibitors and tamoxifen in reducing subsequent breast cancer.
Reina Haque, Syed A Ahmed, Alice Fisher, Chantal C Avila, Jiaxiao Shi, Amy Guo, T Craig Cheetham, Joanne E Schottinger. Cancer Med 2012
19
26

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer.
A Howell, J Cuzick, M Baum, A Buzdar, M Dowsett, J F Forbes, G Hoctin-Boes, J Houghton, G Y Locker, J S Tobias. Lancet 2005
10

A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer.
R Charles Coombes, Emma Hall, Lorna J Gibson, Robert Paridaens, Jacek Jassem, Thierry Delozier, Stephen E Jones, Isabel Alvarez, Gianfilippo Bertelli, Olaf Ortmann,[...]. N Engl J Med 2004
10


Heterogeneity of breast cancer subtypes and survival among Hispanic women with invasive breast cancer in California.
Matthew P Banegas, Li Tao, Sean Altekruse, William F Anderson, Esther M John, Christina A Clarke, Scarlett L Gomez. Breast Cancer Res Treat 2014
37
13

Adult body size, hormone receptor status, and premenopausal breast cancer risk in a multiethnic population: the San Francisco Bay Area breast cancer study.
Esther M John, Meera Sangaramoorthy, Amanda I Phipps, Jocelyn Koo, Pamela L Horn-Ross. Am J Epidemiol 2011
49
8


Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status--a meta-analysis.
Reiko Suzuki, Nicola Orsini, Shigehira Saji, Timothy J Key, Alicja Wolk. Int J Cancer 2009
204
8

Triple-negative breast cancer and obesity in a rural Appalachian population.
Linda Vona-Davis, David P Rose, Hannah Hazard, Marissa Howard-McNatt, Farrell Adkins, Jessica Partin, Gerald Hobbs. Cancer Epidemiol Biomarkers Prev 2008
93
8

Prevalence and type of BRCA mutations in Hispanics undergoing genetic cancer risk assessment in the southwestern United States: a report from the Clinical Cancer Genetics Community Research Network.
Jeffrey N Weitzel, Jessica Clague, Arelis Martir-Negron, Raquel Ogaz, Josef Herzog, Charité Ricker, Chelsy Jungbluth, Cheryl Cina, Paul Duncan, Gary Unzeitig,[...]. J Clin Oncol 2013
101
8

Physical activity and risk of breast cancer: a meta-analysis of prospective studies.
Yili Wu, Dongfeng Zhang, Shan Kang. Breast Cancer Res Treat 2013
221
8

Age-specific incidence of breast cancer subtypes: understanding the black-white crossover.
Christina A Clarke, Theresa H M Keegan, Juan Yang, David J Press, Allison W Kurian, Anish H Patel, James V Lacey. J Natl Cancer Inst 2012
139
8

Genetic variation in genes involved in hormones, inflammation and energetic factors and breast cancer risk in an admixed population.
Martha L Slattery, Esther M John, Gabriela Torres-Mejia, Abbie Lundgreen, Jennifer S Herrick, Kathy B Baumgartner, Lisa M Hines, Mariana C Stern, Roger K Wolff. Carcinogenesis 2012
59
8

Body size, weight change, fat distribution and breast cancer risk in Hispanic and non-Hispanic white women.
Martha L Slattery, Carol Sweeney, Sandra Edwards, Jennifer Herrick, Kathy Baumgartner, Roger Wolff, Maureen Murtaugh, Richard Baumgartner, Anna Giuliano, Tim Byers. Breast Cancer Res Treat 2007
118
8

Breast cancer statistics, 2013.
Carol DeSantis, Jiemin Ma, Leah Bryan, Ahmedin Jemal. CA Cancer J Clin 2014
8

Meta-analysis of survival in African American and white American patients with breast cancer: ethnicity compared with socioeconomic status.
Lisa A Newman, Kent A Griffith, Ismail Jatoi, Michael S Simon, Joseph P Crowe, Graham A Colditz. J Clin Oncol 2006
247
8

The change from brand-name to generic aromatase inhibitors and hormone therapy adherence for early-stage breast cancer.
Dawn L Hershman, Jennifer Tsui, Jay Meyer, Sherry Glied, Grace Clarke Hillyer, Jason D Wright, Alfred I Neugut. J Natl Cancer Inst 2014
63
8

Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer.
Ann H Partridge, Andrea LaFountain, Erica Mayer, Brooke S Taylor, Eric Winer, Aviva Asnis-Alibozek. J Clin Oncol 2008
359
8

Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State.
Betsy A Kohler, Recinda L Sherman, Nadia Howlader, Ahmedin Jemal, A Blythe Ryerson, Kevin A Henry, Francis P Boscoe, Kathleen A Cronin, Andrew Lake, Anne-Michelle Noone,[...]. J Natl Cancer Inst 2015
450
8

Initiation of adjuvant hormone therapy by Medicaid insured women with nonmetastatic breast cancer.
Rachel L Yung, Michael J Hassett, Kun Chen, Foster C Gesten, Patrick J Roohan, Francis P Boscoe, Amber H Sinclair, Maria J Schymura, Deborah Schrag. J Natl Cancer Inst 2012
20
20

Breast cancer statistics, 2015: Convergence of incidence rates between black and white women.
Carol E DeSantis, Stacey A Fedewa, Ann Goding Sauer, Joan L Kramer, Robert A Smith, Ahmedin Jemal. CA Cancer J Clin 2016
709
8

Racial/Ethnic and socioeconomic disparities in endocrine therapy adherence in breast cancer: a systematic review.
Megan C Roberts, Stephanie B Wheeler, Katherine Reeder-Hayes. Am J Public Health 2015
61
8

Patient beliefs and tamoxifen discontinuance in older women with estrogen receptor--positive breast cancer.
Aliza K Fink, Jerry Gurwitz, William Rakowski, Edward Guadagnoli, Rebecca A Silliman. J Clin Oncol 2004
209
8

Self-reported compliance with capecitabine: findings from a prospective cohort analysis.
Ralph Winterhalder, Pierre Hoesli, Geoffrey Delmore, Stefanie Pederiva, Albéric Bressoud, Frank Hermann, Roger von Moos. Oncology 2011
48
8


Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy.
P W Choo, C S Rand, T S Inui, M L Lee, E Cain, M Cordeiro-Breault, C Canning, R Platt. Med Care 1999
453
8

Adherence to long-term therapies: evidence for action.
Sabina De Geest, Eduardo Sabaté. Eur J Cardiovasc Nurs 2003
231
8



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.